| Literature DB >> 35458161 |
Myunghee Kim1, Hyeyoon Eo2, Josephine Gahyun Lim1, Hyunjung Lim3, Yunsook Lim1.
Abstract
Vitamin E plays an important role in attenuating muscle damage caused by oxidative stress and inflammation. Despites of beneficial effects from antioxidant supplementation, effects of antioxidants on exercise-induced muscle damage are still unclear. The aim of this meta-analysis was to investigate the effects of dietary vitamin E supplementation on exercise-induced muscle damage, oxidative stress, and inflammation in randomized controlled trials (RCTs). The literature search was conducted through PubMed, Medline, Science Direct, Scopus, SPORTDiscuss, EBSCO, Google Scholar database up to February 2022. A total of 44 RCTs were selected, quality was assessed according to the Cochrane collaboration risk of bias tool (CCRBT), and they were analyzed by Revman 5.3. Dietary vitamin E supplementation had a protective effect on muscle damage represented by creatine kinase (CK; SMD -1.00, 95% CI: -1.95, -0.06) and lactate dehydrogenase (SMD -1.80, 95% CI: -3.21, -0.39). Muscle damage was more reduced when CK was measured immediately after exercise (SMD -1.89, 95% CI: -3.39, -0.39) and subjects were athletes (SMD -5.15, 95% CI: -9.92, -0.39). Especially vitamin E supplementation lower than 500 IU had more beneficial effects on exercise-induced muscle damage as measured by CK (SMD -1.94, 95% CI: -2.99, -0.89). In conclusion, dietary vitamin E supplementation lower than 500 IU could prevent exercise-induced muscle damage and had greater impact on athletes.Entities:
Keywords: exercise; inflammation; muscle damage; oxidative stress; vitamin E
Mesh:
Substances:
Year: 2022 PMID: 35458161 PMCID: PMC9027756 DOI: 10.3390/nu14081599
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 6.706
Figure 1Flow chart illustrating the study selection process.
Characteristics of included studies for the meta-analysis of effects of dietary vitamin E supplementation.
| Study | Year | Study | Supplementation | Subjects | Exercise Protocol | Measurement | Muscle Damage | Oxidative Stress | Inflammation | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (First Author) | Design | Duration (day) | Daily Dosage (IU) | (Number, Age) | Marker | Effect | Marker | Effect | Marker | Effect | |||
| Santos S.A. [ | 2016 | RCT, | Single dose (1) | 302.5 | 9, healthy males, | 60 min at an intensity of 70% VT I in normoxia and hypoxia simulating an altitude of 4200 m | before and immediately, at 1 h after exercise | CK | ↓ | IL-6 | ↓ | ||
| Schulpis K.H. [ | 2007 | RCT | 30 | 300 | 10, male basketball players, | Stretching, technical-tactical part, a heavy training load part | before, immediately after the training | CK | ↓ | TAS | ↓ | ||
| Gaeini A.A. [ | 2006 | RCT, | 42 | 672 | 20, male students, 23.1 ± 2.0 years | incremental exercise test | before and immediately after exercise | CK | ↔ | MDA | ↔ | ||
| Avery N.G. [ | 2003 | RCT, double-blind design | 31 | 1200 | 18, healthy men, | repeated bouts of whole-body resistance exercise | each day beginning with the first exercise session at, 24 h and 48 h after exercise | CK | ↑ | MDA | ↔ | ||
| Sacheck J.M. [ | 2003 | RCT, | 84 | 1000 | 16, healthy men, 26.4 ± 3.3 years | ran downhill for 45 min at 75% VO2 max | before (baseline) and immediately after exercise (0 h), and at 6, 24, and 72 h after exercise | CK | ↓ | MDA | ↔ | ||
| Itoh H. [ | 2000 | RCT, | 28 | 1200 | 14, male students, 21.1 ± 2.3 years | 6-day running training session (48.3 ± 5.7 km × day–1) | baseline, the day immediately before, the next day after, and three weeks after the 6 day running training | CK | ↓ | MDA | ↓ | ||
| Mcbride J.M. [ | 1998 | RCT | 14 | 1200 | 12, weight-trained males VE: 22.2 ± 0.7 years P: 22.0 ± 0.9 years | heavy resistance exercise | before and at 24 h and 48 h after exercise | CK | ↓ | MDA | ↑ | ||
| Bryant R.J. [ | 2003 | RCT, | 21 | 400 | 7, male cyclists, 22.3 ± 2 years | 60 min steady state ride and a 30-min performance ride | before and immediately after exercise | MDA | ↓ | ||||
| Viitala P.E. [ | 2004 | RCT, | 14 | 1318 | 27, males and females, ages of 19 and 30 years | resistance exercise test | before and immediately and 6 h after exercise | MDA | ↔ | ||||
| Niess A.M. [ | 2002 | RCT, | 8 | 500 | 9, healthy males, 25.3 ± 1.0 years | incremental exercise test + continuous run | before the beginning of supplementation and 3, 24 and 48 h after the end of the continuous run | CK | ↓ | ||||
| Schneider M. [ | 2003 | RCT, crossover design | 8 | 500 | 13, males, 26.5 ± 0.9 years | incremental exercise test + continuous run | at rest, 0, 0.25, 1, 3, 24 and 48 h after exercise. | CK | ↔ | ||||
| Tsakiris S. [ | 2009 | RCT | 30 | 300 | 10, male basketball players, 18.5 ± 0.6 years | training program two or three times a week | before, immediately after the training | CK | ↓ | TAS | ↓ | ||
| Hartmann A. [ | 1995 | RCT | 14 | 1200 | 8, men, | a single bout of exhaustive exercise | before and at 15 min and 24 h after exercise | MDA | ↓ | ||||
| Sumida [ | 1989 | RCT | 28 | 447 | 21, | incremental | before, immediately after exhaustion, and at 1 and 3 h in the recovery period. | MDA | ↓ | ||||
| Silva L.A. [ | 2010 | RCT, | 14 | 800 | 21, male volunteers, | EE | days 0, 2, 4, and 7 after EE | MDA | ↓ | ||||
| Akova B. [ | 2001 | RCT | 56 | 300 | 18, sedentary women, 19–35 years | fatigue test | before and after the exercise | MDA | ↔ | ||||
| Niess A.M. [ | 2000 | RCT, double-blind design | 56 | 500 | 38, triathletes, | the race included a 3.9-km ocean swim, 180-km bike race and 42-km run | before the race, at 0 h, 3 h, 24 h, and 48 h postrace | IL-6 | ↑ | ||||
Abbreviations: CK, creatine kinase; LDH, lactate dehydrogenase; MDA, malondialdehyde; TAS, total antioxidant status; IL-6, interleukin-6; IL-10, interleukin-10; RCT, randomized controlled trial; VT, ventilatory threshold; EE, eccentric exercise; VE, Vitamin E supplementation; P, Placebo; ↓, decrease; ↑, increase; ↔, no difference.
Figure 2Quality analysis of RCTs included in the meta-analysis (+, ‘yes’; ?, ‘unclear’).
Figure 3Forest plot for overall effects of vitamin E supplementation on CK (A) and LDH (B) CK, creatine kinase; LDH, lactate dehydrogenase; SD, standard deviation; SE, standard error; CI, confidence interval; df, degrees of freedom; a, measurement immediately after exercise; b, measurement at 24 h after exercise; c, measurement at 48 h after exercise. Green squares represent the weighted mean difference (WMD) of each study and the black diamond represents the summary of weight mean difference.
Results of subgroup analysis for the effect of vitamin E supplementation on CK concentration.
| Group | No. of Subject | Std, Mean Difference |
| Pheterogeneity | I2 (%) |
|---|---|---|---|---|---|
|
| 288 | −1.00, (−1.95 to −0.06) | 0.04 | <0.00001 | 90 |
|
| |||||
| Immediately after exercise | 122 | −1.89, (−3.39 to −0.39) | 0.01 | <0.00001 | 91 |
| at 24 h after exercise | 104 | −0.084, (−2.31 to 0.63) | 0.26 | <0.00001 | 88 |
| at 48 h after exercise | 61 | 0.71, (−2.43 to 3.86) | 0.66 | <0.00001 | 94 |
|
| |||||
| ≤500 | 190 | −1.94, (−2.99 to −0.89) | 0.0003 | <0.00001 | 88 |
| >500 | 98 | 0.73, (−1.27 to 2.73) | 0.48 | <0.00001 | 92 |
|
| |||||
| Athlete | 52 | −5.15, (−9.92 to −0.39) | 0.03 | <0.00001 | 93 |
| Non-athlete | 236 | −0.31, (−1.21 to 0.58) | 0.49 | <0.00001 | 88 |
Figure 4Forest plot for overall effects of vitamin E supplementation on MDA (A) and TAS (B) MDA, malondialdehydes; TAS, total antioxidant status; SD, standard deviation; SE, standard error; CI, confidence interval; df, degrees of freedom; a, measurement immediately after exercise; b, measurement at 24 h after exercise; c, measurement at 48 h after exercise; x, pre-training exercise test; y, post-training exercise test. Green squares represent the weighted mean difference (WMD) of each study and the black diamond represents the summary of weight mean difference.
Results of subgroup analysis for effects of vitamin E supplementation on MDA concentration.
| Group | No. of Subject | Std, Mean Difference in CK, U/L (95%CI) |
| Pheterogeneity | I2 (%) |
|---|---|---|---|---|---|
|
| 249 | −0.17, (−0.52 to 0.18) | 0.35 | 0.04 | 42 |
|
| |||||
| Immediately after exercise | 126 | −0.21, (−0.57 to 0.14) | 0.24 | 0.71 | 0 |
| at 24 h after exercise | 72 | 0.20, (−0.41 to 0.81) | 0.52 | 0.36 | 37 |
| at 48 h after exercise | 51 | −0.92, (−2.23 to 0.39) | 0.17 | 0.04 | 76 |
|
| |||||
| ≤500 | 74 | −0.48, (−0.95 to −0.01) | 0.04 | 0.53 | 0 |
| >500 | 175 | −0.06, (−0.49 to 0.38) | 0.62 | 0.04 | 47 |
|
| |||||
| Athlete | 38 | −0.55, (−2.00 to 0.90) | 0.46 | 0.002 | 80 |
| Non-athlete | 211 | −0.15, (−0.43 to 0.13) | 0.30 | 0.68 | 0 |
Figure 5Forest plot for an overall effect of vitamin E supplementation on IL-6 (interleukin-6); SD, standard deviation; CI, confidence interval; df, degrees of freedom; a, measurement immediately after exercise; b, measurement at 24 h after exercise. Green squares represent the weighted mean difference (WMD) of each study and the black diamond represents the summary of weight mean difference.